camptothecin has been researched along with 1,2-dilauroylphosphatidylcholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilbert, BE; Knight, V; Koshkina, NV; Seryshev, A; Waldrep, JC | 1 |
| Gilbert, BE; Giovanella, BC; Kleinerman, ES; Knight, V; Koshkina, NV; Waldrep, JC | 1 |
2 other study(ies) available for camptothecin and 1,2-dilauroylphosphatidylcholine
| Article | Year |
|---|---|
Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice.
Topics: Aerosols; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Carriers; Female; Humans; Injections, Intramuscular; Liposomes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Phosphatidylcholines | 1999 |
9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice.
Topics: Aerosols; Animals; Antineoplastic Agents; Bone Neoplasms; Camptothecin; Colonic Neoplasms; Drug Carriers; Female; Humans; Liposomes; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Microscopy, Electron; Osteosarcoma; Particle Size; Phosphatidylcholines; Xenograft Model Antitumor Assays | 2000 |